An italian biopharmaceutical company
The company is focused on the discovery, development and commercialization of monoclonal antibodies
Managing Team
Stefano Iacobelli, M.D.
Founder & President
Piergiorgio Natali, M.D.
Founder & Chief Scientific Officer
Raffaella Muraro, M.D.
Research & Development Consultant
Nicola Tinari, M.D.
Research & Development Consultant
Mauro Piantelli, M.D.
Research & Development Consultant
Antonio Zangrilli
Chief Regulatory Affairs
Graziano D'Intino
Finance Accounting
Riccardo Palumbo
Business Management
Tag Cloud
Istituto Superiore di Sanita
Research & Development
development
pharmaceutical company
research
European Venture contest
Scientific Advisory Board
biopharmaceutical company
Targeted therapy
research antibodies
Cancer biological therapy
Monoclonal antibodies
products based on monoclonal antibodies
Cancer biodiagnostics
Cancer diagnosis
Business development
Antibody production
European cancer drug company
Therapeutic antibodies
Mouse monoclonal
Cancer drug companies
Legal Disclaimer
Cancer targeted therapy
SP-2 0.1 mg Affinity purified
product pipeline
Subscribe to Rss Feed
ShareMediaPharma S.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.
